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Abstract
Background: Due to language limitations, the abstract of journal article may be the only way for people of non-
Chinese speaking countries to know about trials in traditional Chinese medicine (TCM). However, little is known about 
the reporting quality of these trial abstracts. Our study is to assess the reporting quality of abstracts of randomized 
controlled trials (RCT) published in four leading Chinese medical journals of TCM, and to identify any differences in 
reporting between the Chinese and English version of the same abstract publication.
Method: Two reviewers hand-searched the Chinese Journal of Integrated Traditional and Western Medicine, the 
Chinese Journal of Integrative Medicine, the China Journal of Chinese Materia Medica and the Chinese Acupuncture & 
Moxibustion for all abstracts of RCTs published between 2006 and 2007. Two reviewers independently assessed the 
reporting quality of the Chinese and English version of all eligible abstracts based on a modified version of the 
CONSORT for reporting randomised trials in journal and conference abstracts (CONSORT for abstracts).
Results: We identified a total of 345 RCTs of TCM with both a Chinese and English abstract. More than half of Chinese 
abstracts reported details of the trial participants (68%; 234/345), control group intervention (52%; 179/345), the 
number of participants randomized (73%; 253/345) and benefits when interpreting the trial results (55%; 190/345). 
Reporting of methodological quality or key features of trial design and trial results were poor; only 2% (7/345) included 
details of the trial design, 3% (11/345) defined the primary outcome, 5% (17/345) described the methods of random 
sequence generation, and only 4% (13/345) reported the number of participants analyzed. No abstracts provided 
details on allocation concealment and trial registration. The percentage agreement in reporting (between the Chinese 
and English version of the same abstract) ranged from 84% to 100% across individual checklist item.
Conclusion: The reporting quality of abstracts of RCTs published in these four TCM journals needs to be improved. 
Since none of the four journals adopted CONSORT for Abstracts, we hope that the introduction and adoption of 
CONSORT for Abstracts by TCM journals will lead to an improvement in reporting quality.
Background
Traditional Chinese medicine (TCM) plays an important
role in maintaining the health of the Chinese population
(especially before the introduction of western medicine
into China) and its benefits are gradually being recog-
nized worldwide. A number of randomized controlled
trials (RCT) are conducted assessing the efficacy and
safety of TCM, the majority of which are published in
Chinese in Chinese medical journals with only the
abstract being translated into English.
Health professionals often rely on the abstract of a jour-
nal article to decide whether to retrieve the full-text. In
countries with limited resources to access the full-text,
sometimes health care decisions are made based only on
the information reported in the abstracts [1,2]. In TCM
this problem is exemplified as the English abstract may be
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the only way for non-Chinese speaking countries to know
about RCTs of TCM.
It is therefore important that abstracts of RCTs provide
details of the trial participants, interventions, methodol-
ogy (such as details of randomization, blinding, and
intention-to-treat analysis) and the importance of the
trial results (including estimates of benefits and harms,
and their precision). To date, little is known about the
quality of reporting of RCT abstracts in TCM. This study
aims to assess and compare the reporting quality of both
Chinese and English abstracts of RCTs published in four
leading TCM Chinese medical journals using the recent
CONSORT for reporting randomised trials in journal
and conference abstracts (CONSORT for abstracts) [3].
Methods
Selection of journals
We selected four MEDLINE-indexed Chinese medical
journals (Chinese Acupuncture & Moxibustion, Chinese
Journal of Integrated Traditional and Western Medicine,
Chinese Journal of Integrative Medicine, China Journal of
Chinese Materia Medica) of TCM with a top ranking
impact factor (IF) (ranked as No. 2, 3, 4 and 7) among the
38 journals in the category of Chinese traditional medi-
cine and Chinese materia medica based on the 2007 data
for Sci-tech Journal Citation Reports of China (Table 1).
We selected these four high impact journals as they are
indexed in MEDLINE and each abstract to be reported in
English.
Identification of RCTs
Two reviewers (L Wang and YL Li) hand searched the
f o u r  j o u r n a l s  i n d e p e n d e n t l y .  W e  i n c l u d e d  a l l  a b s t r a c t s
published between 2006 and 2007 that mentioned "ran-
domization", "randomized allocation" or "randomized" in
the abstract or full text. We excluded the abstracts
reported as "quasi-randomized controlled trials", "labora-
tory study", "randomized sampling study", "meta-analy-
sis", or "systematic review". All the eligible abstracts were
retrieved from the full text database CNKI (China
National Knowledge Infrastructure/Chinese Academic
Journals full text Database).
Assessment of abstracts
We assessed the reporting quality of included Chinese
and English abstracts based on criteria outlined in the
CONSORT for abstracts [4]. We refined several of the
items included in the CONSORT for Abstracts checklist
to assess certain items in more detail and to add some
unique characteristics relevant to TCM. For example, we
expanded "interventions" to "interventions intended for
experimental group" and "interventions intended for con-
trol group", and expanded the item "blinding" to "speci-
fied exactly who was blinded" and "simply described the
trials as single blind or double blind". We assessed each
item as being "reported" or "not reported" according to
whether the author had reported all the contents listed in
the refined items or not.
Two reviewers (L Wang and YL Li) assessed each
abstract independently after discussing and comprehend-
ing the items thoroughly with J Li and MM Zhang. We
sought further clarification from S Hopewell if there was
any problem with understanding of the CONSORT for
Abstracts checklist criteria. A pilot study was performed
on 10 RCT abstracts selected at random (both the Chi-
nese and English version of the same abstract) and inter
rater agreement was calculated using the kappa statistic.
Discrepancies were resolved by discussion. Once we had
ensured consistency in the interpretation of the data
extraction form we carried out double data extraction on
all remaining abstracts. We determined the overall num-
ber and proportion (%) of RCT abstracts that reported
each of the CONSORT for Abstracts item. We also
assessed the consistency in reporting between the Chi-
nese and English version of the same abstract using the
kappa statistics. Data were analyzed using Microsoft
Excel 2003 and SAS version 9.1.
Table 1: Number of abstracts identified and included from four TCM a of Chinese medical journals (2006 to 2007)
Journals IF b Identified RCTc Included abstracts
Chinese Acupuncture and Moxibustion 0.437 165 154
Chinese Journal of Integrated Traditional and Western Medicine 0.837 261 158
Chinese Journal of Integrative Medicine 0.598 21 19
China Journal of Chinese Materia Medica 0.634 48 14
Total 495 345
a TCM: traditional Chinese medicine
b Impact factor (IF) comes from «2007 data for sci-tech Journal Citation Reports of China»
c RCT: randomized controlled trialWang et al. Trials 2010, 11:75
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Results
We identified 495 RCTs from hand searching the full-text
and abstracts of the four leading TCM journals from 2006
to 2007, of which 345 (70%) included both the Chinese
and English version of the same abstracts and all were
structured abstracts as it is a formal requirement for the
four journals. The remaining 150 RCTs were published as
short reports with no abstract. Seven RCT reports men-
tioned "randomized" in the abstract but not in the full
text, while 18 mentioned "randomized" in the full text but
not in the abstract. Eighty-five papers mentioned "ran-
domized" in the abstract but were judged as "quasi-ran-
domization" after reading the full text. Table 1 provides
information on the impact factor for the four journals,
the number of RCTs identified and the number of reports
with both the Chinese and English version of the same
abstracts for each journal. Agreement between the two
reviewers was good with a kappa score of greater than
0.75 for each item.
Table 2 presents the criteria used to judge whether the
abstract reported the item, and the number and propor-
tion (%) of items reported for both the Chinese and Eng-
lish version of the same abstracts.
Reporting quality of Chinese RCT abstracts
General items
Only 8% (28/345) abstracts could be judged as RCTs from
their titles, other abstracts were most described as "clini-
cal trial", "comparison research", "effect comparison", or
"effect observation". Only one (1/345) abstract did not
report the author's addresses, seven abstracts reported
the trial design as "parallel comparison RCTs", no abstract
reported details of trial registration and only 27% (93/
345) reported the source of funding.
Trial methodology
A total of 68% (234/345) of abstracts reported details of
participants included in the trial; the remainder simply
used the term "patient". Forty-seven percent (163/345) of
abstracts reported details of the experimental interven-
tion and 52% (179/345) the control intervention. Forty-
two percent (144/345) of abstracts reported the name of
the experimental intervention and 27% (92/345) the con-
trol intervention, 11% (38/345) described the experimen-
tal intervention as "Chinese medicine" and 21% (74/345)
of the control intervention as "western medicine". Only
14% (48/345) of abstracts reported the study objective,
5% (17/345) the method of random sequence generation;
no abstracts mentioned details of allocation concealment.
A total of 11% (39/345) mentioned the trial as "single
blind" or "double blind"; only one specified exactly who
was blinded.
Trial results
Seventy-three percent (253/345) of abstracts reported the
number of participants randomized to each group, how-
ever, only 4% (13/345) reported the number of partici-
pants included in the analysis. Fifty-seven percent (195/
345) of abstracts reported the result for each group and
44% (150/345) reported a P value for the between-group
comparison, however only two abstracts reported the
effect size and its precision. Fifteen percent (50/345) of
abstracts mentioned adverse events or side effects of the
treatment.
Trial conclusion
Four abstracts clearly stated the benefits and harms of the
results when interpreting the clinical application, with
55% (190/345) of abstracts reporting only the benefits.
Comparison of the Chinese and English of the same RCT 
abstracts
The proportion of abstracts reporting each checklist item
was almost the same between the Chinese and corre-
sponding English abstracts (Table 3). The percentage
agreement in reporting (between the Chinese and English
version of the same abstracts) ranged from 84% to 100%
across individual checklist item. The median of kappa
statistic for each item was 0.86 (0.64-1.00). The items
where there was most disparity between the Chinese and
English abstracts were details of the trial participants and
the number of participants randomized.
Discussion
Our study identified 345 of RCTs published in four lead-
ing Chinese TCM journals with both the Chinese and
English version of the same abstracts between 2006 and
2007. Based on the CONSORT for Abstract checklist cri-
teria, the quality of reporting of trial abstracts in these
journals was far from satisfactory. Except for details of
the trial authors, participants, the intervention for con-
trol group, and the number of participants randomized in
the trial, all other items were reported in less than half of
the abstract reports. Reporting of methodological quality
or key features of trial design and trial results was even
worse. Less than 5% of the included abstracts fully or cor-
rectly reported relevant items including details of the trial
design, clearly defining the primary outcome, the method
of random sequence generation and allocation conceal-
ment, specifying details on who was blinded, the number
of participant analyzed in each arm of the trial, and the
estimated effect size and its precision for the primary
outcome.
Our study has several strengths. We hand searched four
h i g h  i m p a c t  T C M  m e d i c a l  j o u r n a l s  t o  e n s u r e  t h a t  a l l
RCTs were identified. In addition, all items in modified
version of the CONSORT for Abstracts checklist were
carefully discussed and understood within the research
team. The identification of RCTs, eligibility decision and
data extraction were conducted in duplicate. However,
our study has limitations. We did not take a random sam-
ple of all RCT published in TCM medical journals andWang et al. Trials 2010, 11:75
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therefore our findings may not reflect the whole picture
of reporting quality of trial abstracts in the TCM field.
Our findings are consistent with or worse than previous
studies that have assessed the quality of reporting of jour-
nals RCT abstracts and conference RCT abstracts. Previ-
ous work has shown that abstracts frequently under
report key features of study design [1,2,5] and omit
important results. In the mid-1990s, Li and Hu reported
that the quality of abstracts in Chinese medical journals
was poor [6,7]. The problem is particularly apparently
when trying to assess details of methodological quality. A
recent study evaluating 227 RCT abstracts published in
four high impact general medical journals in 2006 found
that only one abstract reported details of allocation con-
cealment, 23% reported the use of intention-to-treat
analysis, 14% reported loss of follow-up, and 9% reported
details of blinding [8]. A further study evaluating RCT
abstracts presented at the American Society of Clinical
Oncology Conference and found no abstracts reported
allocation concealment, 16% reported on blinding, and
only 14% reported intention-to-analysis [9].
Possible explanations for our findings of poor reporting
include poor reporting of RCT full-text articles in China,
when an item isn't reported in the full publication, it may
Table 2: Criteria for assessing the quality of reporting of abstracts of RCTs in TCM
Items Criteria for judgment No. of abstracts reporting 
each item (n = 345)
Chinese (%) English (%)
General items
Title Mentioned randomized or randomly allocation in the title 28(8) 25(7)
Authors Reported the contact details of corresponding author, e.g. postal address, email 344(99) 344(99)
Trial design Described as "parallel group", "cluster randomized", "crossover", etc. 7(2) 5(1)
Trial registration Reported the trial registration number and name of trial register 0(0) 0(0)
Funding Reported the source of funding for the trial 93(27) 0(0)
Methods
Participants Reported the details of the participants (included the demography, diagnosis, TCM 
syndrome)
234(68) 239(69)
Interventions Reported the details of the interventions for experimental group (included denomination, 
usage and course of treatment)
163(47) 152(44)
Reported the details of the interventions for control group (included denomination, usage 
and course of treatment)
179(52) 168(49)
Objective Described as "to compare interventions(A) and (B) in patients with condition(C)" 48(14) 44(13)
Outcome Defined the primary outcome 11(3) 10(3)
Randomization Reported the method of random sequence generation 17(5) 14(4)
Mentioned the allocation concealment (such as central randomization by telephone) 0(0) 0(0)
Blinding Specified exactly who was blinded 1(0.3) 0(0)
Simply mentioned the trial as "single blind", or "double blind" 39(11) 39(11)
Results
Numbers 
randomized
Reported the number of participants randomized to each group 253(73) 253(73)
Numbers analyzed Reported the number of participants included in analysis for each group 13(4) 12(4)
Outcomes Reported the result for each group (if the primary outcome not defined, reported the result 
of one listed outcome)
195(57) 190(55)
Reported effect size, precision for the difference between groups 2(1) 2(1)
Harms Reported important adverse events or side effects 50(15) 48(14)
Conclusions
Clearly stated the benefits and harms when interpreting the results 4(1) 3(1)
Only stated the benefits when interpreting the results 190(55) 190(55)Wang et al. Trials 2010, 11:75
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also be missing from the abstract. A study evaluating the
reporting quality of 142 RCT full-text articles published
in five leading Chinese medical journals found that only
27% described the method to generate the randomized
sequence, 4% had adequate allocation concealment, and
only 17% mentioned blinding [10]; these findings are sup-
ported by others in the field of TCM [11,12].
Lack of detailed requirements for structured abstracts
in journal's "Instruction for Authors" in China is also a
problem since none of the journals included in our study
mentioned CONSORT for Abstracts in their Instructions
to Authors. Some studies have proved that journal adop-
tion of structured abstracts can improve the reporting of
abstracts [13-17]. Although most of the Chinese medical
journals have adopted four-heading structured abstracts
(objectives, methods, results and conclusion), the struc-
tured format alone is insufficient to guide authors regard-
ing their content for reporting RCTs.
Finally, the word limitation of an abstract restricts the
amount of detail an author is able to provide. Most Chi-
nese medical journals have abstract word restrictions,
usually within 150-500 Chinese words, making it difficult
for authors to comprehensively report trial methods and
results, especially when authors are not aware the impor-
tance of research methodology and the way to correctly
present the clinical relevance of research results. The
word limit for the journals we assessed is 150-250 Chi-
nese words and 150-400 English words.
Conclusion
In summary, we found that the quality of reporting of
trial abstracts in these four leading TCM medical journals
is far from satisfactory, especially with respect to details
of the trial methodology. Many studies have proved that
adoption of the CONSORT Statement has demonstrated
benefits in improving the reporting quality of RCT of
full-text articles [18], and we hope that it will do the same
with the introduction of CONSORT for Abstracts in Chi-
nese medical journals of TCM field.
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